Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Neurofibromatosis 1Chronic Pain
Interventions
DEVICE

iCanCope

The iCanCope mobile and web-based self-management program has been empirically evaluated for multiple painful diseases

DEVICE

iCanCope+Contingency Management

In addition to the iCanCope-NF activities outlined above, individuals will be rewarded with incentives (contingency management) such as points that are redeemable for prize-based gift card vouchers. Points will be accrued through access to new sections, daily check-ins, and engagement of the mobile application. Based on research, the total amount of money that can be earned by the patient over the course of the two months is 50 dollars USD.

Trial Locations (1)

06510

Frank D Buono, PHD, New Haven

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

The Hospital for Sick Children

OTHER

collaborator

Connecticut Children's Medical Center

OTHER

lead

Yale University

OTHER

NCT04561765 - Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial | Biotech Hunter | Biotech Hunter